A study undertaken by Dr. Mark Heaney and colleagues at the Memorial Sloan-Kettering Cancer Center in New York published findings yesterday claiming that Vitamin C supplements may reduce the efficacy of cancer drugs including Novartis' Gleevec.
Vitamin C treated human cancer cells were tested with chemotherapy drugs in lab dishes. The drugs administered killed between thirty and seventy ...